Showing results (181-190 of 212) with videos related to
Sort By:
Pageof 22
Biological Research for Nursing|January 31, 2014
Baseline immune biomarkers as predictors of MBSR(BC) treatment success in off-treatment breast cancer patientsRichard R Reich, Cecile A Lengacher, Kevin E Kip, et al.Circulation|September 1, 1999
Influence of pre-PTCA strategy and initial PTCA result in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI)K E Kip, M G Bourassa, A K Jacobs, et al.Circulation|August 23, 2006
The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health--National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome EvaluationLeslee J Shaw, C Noel Bairey Merz, Carl J Pepine, et al.JACC. Cardiovascular Interventions|February 13, 2009
Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic RegistrySuresh R Mulukutla, Helen A Vlachos, Oscar C Marroquin, et al.Journal of Pain and Symptom Management|October 11, 2016
Mindfulness-Based Stress Reduction in Post-treatment Breast Cancer Patients: Immediate and Sustained Effects Across Multiple Symptom ClustersRichard R Reich, Cecile A Lengacher, Carissa B Alinat, et al.Circulation. Cardiovascular Interventions|February 2, 2010
Paclitaxel-eluting versus sirolimus-eluting stents in diabetes mellitus: a report from the National Heart, Lung, and Blood Institute Dynamic RegistryWilliam M Wolf, Helen A Vlachos, Oscar C Marroquin, et al.Psycho-Oncology|July 1, 2017
Feasibility of the mobile mindfulness-based stress reduction for breast cancer (mMBSR(BC)) program for symptom improvement among breast cancer survivorsCecile A Lengacher, Richard R Reich, Sophia Ramesar, et al.Journal of the American College of Cardiology|May 20, 1999
Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI)M G Bourassa, K E Kip, A K Jacobs, et al.The New England Journal of Medicine|January 25, 2008
A comparison of bare-metal and drug-eluting stents for off-label indicationsOscar C Marroquin, Faith Selzer, Suresh R Mulukutla, et al.The Journal of Antimicrobial Chemotherapy|September 30, 2017
Visceral leishmaniasis relapse hazard is linked to reduced miltefosine exposure in patients from Eastern Africa: a population pharmacokinetic/pharmacodynamic studyThomas P C Dorlo, Anke E Kip, Brima M Younis, et al.Pageof 22